Hourly Med Consumption Behavior - Oncology- Immunomodulators
Provided By: Medisafe Inc.
Hourly Med Consumption Behavior - Oncology- Immunomodulators
Provided By: Medisafe Inc.
Examine medication consumption patterns in granular, down to the hour, details of self-reported and de-identified patients taking Oncology: Immunomodulators to gain insight about specific behaviors.
Product offers
The following offers are available for this product. Choose an offer to view the pricing and access duration options for the offer. Select an offer and continue to subscribe. Your subscription begins on the date that your request is approved by the provider. Additional taxes or fees might apply.
Public offer
Payment schedule: Upfront payment | Offer auto-renewal: Supported
$36,000 for 12 months
Overview
Medisafe has a comprehensive database of de-identified medication adherence activity and behaviors. This product represents one subset of this data. To learn more about our insights- - contact us at dataaws@medisafe.com)
Product Overview: A snapshot of US Medisafe users who report taking an Immunomodulators medication in the most recent completed quarter. The data set includes self-reported and de-identified detailed breakdown of adherence/persistence data by medication, including scheduled reminders and self-reported taken doses. Gain actionable insights by tracking trends, commonalities and outliers from a targeted medication cohort.
- Drug Class: Oncology: Immunomodulators
- Get insight into users’ hourly behaviors and daily compliance
- Establish profiles (de-identified) of high/medium/low adherence tendencies.
- Compare consumption of medication of interest between brands. *Compare self-reported data to other sources of prescription data in your possession.
- Initial dataset file including data from most recently ended quarter
- Subsequent dataset file for most recently ended quarter/month until end of subscription
- Geographic coverage: USA General Description:
Medisafe is the leader of digital therapeutic companions for medication management. Currently there are over six million users world-wide who have incorporated our holistic approach to medication management into their everyday lives. Medisafe has generated over 12 billion data points of de-identified data representing medication behaviors spanning diverse therapeutic areas. Medisafe’s data products are sourced from real-world behaviors while maintaining the highest degree of patient privacy and security protection. Our de-identified data sets combine age and gender demographics, self reported medication management and digital behavior patterns and is both HIPAA and GDPR compliant. The data products offered on AWS are exclusively for qualified research endeavors. If interested in purchasing any of our data products we invite you to submit your request to dataaws@medisafe.com.
Updated: December 5, 2019
Product subscription includes: initial snapshot file from most recent completed quarter of the year, and subsequent quarterly (or monthly) snapshots for duration of annual subscription. Product subscription renewed annually.
Provided By
Fulfillment Method
AWS Data Exchange
Data sets (1)
You will receive access to the following data sets
Revision access rules
All historical revisions | All future revisions
Name | Type | Data dictionary | AWS Region |
---|---|---|---|
Granular Medication Consumption Behavior - Oncology - Immunomodulatory drugs | Not included | US East (N. Virginia) |
Usage information
By subscribing to this product, you agree that your use of this product is subject to the provider's offer terms including pricing information and Data Subscription Agreement . Your use of AWS services remains subject to the AWS Customer Agreement or other agreement with AWS governing your use of such services.
Support information
Support contact email address
Support contact URL
Refund policy
No refunds
General AWS Data Exchange support